SEC Form 4 · accession 0001424422-17-000004
BioPharmX Corp · BPMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Hubbard
Director
Period of report
Apr 18, 2017
Accepted (ET)
Apr 19, 2017 · 5:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001504167
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase common stockF1 | $0.74 | Apr 18, 2017 | A | 200,000 | A | May 18, 2017 | Apr 18, 2027 | Common stock | 200,000 | 200,000 | D |
Explanation of responses
- F1This option vests ratably over 12 months with the first vesting starting on 5/18/17.